Mexico Artificial Intelligence In Drug Discovery Market Size & Outlook

The artificial intelligence in drug discovery market in Mexico is expected to reach a projected revenue of US$ 26.7 million by 2030. A compound annual growth rate of 29.8% is expected of Mexico artificial intelligence in drug discovery market from 2024 to 2030.
Revenue, 2023 (US$M)
$4.3
Forecast, 2030 (US$M)
$26.7
CAGR, 2024 - 2030
29.8%
Report Coverage
Mexico

Mexico artificial intelligence in drug discovery market, 2018-2030 (US$M)

Mexico

Related Markets

Mexico artificial intelligence in drug discovery market highlights

  • The Mexico artificial intelligence in drug discovery market generated a revenue of USD 4.3 million in 2023 and is expected to reach USD 26.7 million by 2030.
  • The Mexico market is expected to grow at a CAGR of 29.8% from 2024 to 2030.
  • In terms of segment, drug optimization & repurposing was the largest revenue generating application in 2023.
  • Drug Optimization & Repurposing is the most lucrative application segment registering the fastest growth during the forecast period.


Artificial intelligence in drug discovery market data book summary

Market revenue in 2023USD 4.3 million
Market revenue in 2030USD 26.7 million
Growth rate29.8% (CAGR from 2023 to 2030)
Largest segmentDrug optimization & repurposing
Fastest growing segmentDrug Optimization & Repurposing
Historical data2018 - 2022
Base year2023
Forecast period2024 - 2030
Quantitative unitsRevenue in USD million
Market segmentationDrug Optimization & Repurposing, Preclinical Testing
Key market players worldwideInternational Business Machines Corp, Exscientia PLC ADR, Alphabet Inc Class A, Benevolent AI, Recursion Pharmaceuticals Inc Class A, Aitia, BioSymetrics, Euretos, Berg, Atomwise, Insitro


Other key industry trends

  • In terms of revenue, Mexico accounted for 0.3% of the global artificial intelligence in drug discovery market in 2023.
  • Country-wise, U.S. is expected to lead the global market in terms of revenue in 2030.
  • In Latin America, Brazil artificial intelligence in drug discovery market is projected to lead the regional market in terms of revenue in 2030.
  • Argentina is the fastest growing regional market in Latin America and is projected to reach USD 28.8 million by 2030.

No credit card required*

Horizon in a snapshot

  • 30K+ Global Market Reports
  • 120K+ Country Reports
  • 1.2M+ Market Statistics
  • 200K+ Company Profiles
  • Industry insights and more

Artificial Intelligence In Drug Discovery Market Scope

Artificial intelligence in drug discovery market segmentation & scope
Consumer Electronics
Healthcare
Automotive
Military & Defense
Media & Entertainment
Drug Discovery & Development
Precision Medicine
Diagnotics
Others
Orthopedics
Neurology
Urology
Gynecology
Processor
Connectivity IC
Sensors

Artificial Intelligence In Drug Discovery Market Companies

Name Profile # Employees HQ Website

Mexico artificial intelligence in drug discovery market outlook

The databook is designed to serve as a comprehensive guide to navigating this sector. The databook focuses on market statistics denoted in the form of revenue and y-o-y growth and CAGR across the globe and regions. A detailed competitive and opportunity analyses related to artificial intelligence in drug discovery market will help companies and investors design strategic landscapes.


Drug optimization & repurposing was the largest segment with a revenue share of 53.49% in 2023. Horizon Databook has segmented the Mexico artificial intelligence in drug discovery market based on drug optimization & repurposing, preclinical testing covering the revenue growth of each sub-segment from 2018 to 2030.


Mexico is making rapid headway in the field of AI. The country has a young talented labor force and is one of the leading countries to announce AI strategies. Increasing prevalence of chronic diseases in the country and growing need to control drug discovery & development costs are factors anticipated to drive the country’s adoption of AI in drug discovery. 

According to the International Diabetes Federation, the prevalence of diabetes among adults is 15.2%, accounting for around 12,805,200 patients in the country. Mexico also has a promising group of startups working to discover new digital solutions for challenges at local and national levels. 

The country has a strong educational community, which is expected to prosper with the right assistance. Local governments are already dedicated to working with civil society on AI implementation. These factors are anticipated to bolster Mexico’s adoption of AI in drug discovery over the forecast period.

Reasons to subscribe to Mexico artificial intelligence in drug discovery market databook:

  • Access to comprehensive data: Horizon Databook provides over 1 million market statistics and 20,000+ reports, offering extensive coverage across various industries and regions.
  • Informed decision making: Subscribers gain insights into market trends, customer preferences, and competitor strategies, empowering informed business decisions.
  • Cost-Effective solution: It's recognized as the world's most cost-effective market research database, offering high ROI through its vast repository of data and reports.
  • Customizable reports: Tailored reports and analytics allow companies to drill down into specific markets, demographics, or product segments, adapting to unique business needs.
  • Strategic advantage: By staying updated with the latest market intelligence, companies can stay ahead of competitors, anticipate industry shifts, and capitalize on emerging opportunities.

Target buyers of Mexico artificial intelligence in drug discovery market databook

  • Our clientele includes a mix of artificial intelligence in drug discovery market companies, investment firms, advisory firms & academic institutions.
  • 30% of our revenue is generated working with investment firms and helping them identify viable opportunity areas.
  • Approximately 65% of our revenue is generated working with competitive intelligence & market intelligence teams of market participants (manufacturers, service providers, etc.).
  • The rest of the revenue is generated working with academic and research not-for-profit institutes. We do our bit of pro-bono by working with these institutions at subsidized rates.

Horizon Databook provides a detailed overview of country-level data and insights on the Mexico artificial intelligence in drug discovery market , including forecasts for subscribers. This country databook contains high-level insights into Mexico artificial intelligence in drug discovery market from 2018 to 2030, including revenue numbers, major trends, and company profiles.

Partial client list

  • logo

Mexico artificial intelligence in drug discovery market size, by application, 2018-2030 (US$M)

Mexico Artificial Intelligence In Drug Discovery Market Outlook Share, 2023 & 2030 (US$M)

Mexico artificial intelligence in drug discovery market size, by application, 2018-2030 (US$M)

Sign up - it's easy, and free!

Sign up and get instant basic access to databook, upgrade
when ready, or enjoy our free plan indefinitely.

Explore all plans

Included in Horizon account

  • 30K+ Global Market Reports
  • 120K+ Country Reports
  • 1.2M+ Market Statistics
  • 200K+ Company Profiles
  • Industry insights and more